Yersinia Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Yersinia is a rod-shaped, gram-positive bacterium in the Enterobacteriaceae family that causes enterocolitis, terminal iletis, mesenteric lymphadenitis, acute diarrhea, and sepsis. The pathogen species of Yersinia include Yersinia pestis, Yersinia enterocolitica, and Yersinia pseudotuberculosis. These species of Yersinia cause the Bubonic plague and gastroenteritis, respectively. The symptoms of the diseases caused by these bacteria include gastroenteritis, vomiting, abdominal pain, low-grade fever and diarrhea. The infection usually occurs in children. This infection affects men more often than women.

MARKET DYNAMICS

The yersinia diagnostics market is driving due to the high prevalence of Yersiniosis, emergence of improved diagnostic technologies such as molecular diagnostics and growing patient awareness levels across the globe. However, less knowledge regarding yersinia diagnostics may hinder the market's growth. Moreover, untapped opportunities in emerging Asian economies, focus on research and increase in research funding are expected to provide opportunities in the yersinia diagnostics market.

MARKET SCOPE

The "Yersinia diagnostics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of yersinia diagnostics market with detailed market segmentation by test, technique, and end user. The yersinia diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in yersinia diagnostics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The yersinia diagnostics market is segmented on the basis of test, technique, and end user. Based on test, the market is segmented as stool culture, ELISA, radioimmunoassay, tube agglutination, CT scan, ultrasonography, colonoscopy. Based on technique, the market is segmented as PCR, DNA probes, monoclonal antibodies, immunoassay, IT, others. Based on end user, the market is segmented as hospital laboratories, public health laboratories, commercial laboratories.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Yersinia diagnostics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The yersinia diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting yersinia diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Yersinia diagnostics market in these regions.

MARKET PLAYERS

The report covers key developments in the yersinia diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Yersinia diagnostics market are anticipated to have lucrative growth opportunities in the future with the rising demand for Yersinia diagnostics in the global market. Below mentioned is the list of few companies engaged in the Yersinia diagnostics market.

The report also includes the profiles of key players in yersinia diagnostics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Abbott
  
•   Gen-probe
  
•   Affymetrix Inc.
  
•   Bio-Rad Laboratories
  
•   Hologic
  
•   Roche
  
•   BD
  
•   Danaher
  
•   Thermo Fisher Scientific Inc.
  
•   bioMérieux SA
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Yersinia Diagnostics Report Scope